Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...
Hosted on MSN20h
Relmada acquires Tourette’s therapy rights from AsarinaRelmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback